Dr. Filip Delport
CTO and co-founder of FOx Biosystems
Supervisor ESR 14 and industry advisor of ESR9; deputy lead of WP4.
“Off course the topic of continuous monitoring, integration in a closed environment and improved bioreceptor surfaces is of strong interest to us as these fit with our core markets and will prove crucial in many newly developing therapeutics and diagnostics.”
FOx Biosystems is a Venture Capital supported university spin-off of the MeBioS-Biosensors group of the KU Leuven. FOx Biosystems offers superior analytical systems, consumables and services with substantial benefits in the development and production of biopharmaceutical and diagnostic products. As CTO Filip manages the technological, biotechnical, regulatory, management and financial aspects needed to create the next generation fiber optic SPR biosensor.
His goal is to develop novel sensor products in the research and development life sciences sector.
Filip Delport started his professional career with a PhD in bionanotechnology at the faculty of Bio-engineering of the KU Leuven. During his post-doctoral work an IWT innovation mandate scholarship was acquired with the goal of preparing the fiber optic SPR biosensor technology towards the creation of a spin-off company. During 2014 until 2019 the technology was developed into a prototype, a business plan was substantiated and funding was acquired until a seed round of 4 M €. He was CEO of the newly founded company until 2020 after which he focussed on the CTO role in the fast growing company.
As a young company, growing a network within Europe for knowledge in biosensing with both academics and industry is crucial. As we operate in a high tech sector, one of the main challenges to grow the company is to get access to promising motivated students.
Off course the topic of continuous monitoring, integration in a closed environment and improved bioreceptor surfaces is of strong interest to us as these fit with our core markets and will prove crucial in many newly developing therapeutics and diagnostics.
K. Knez et al. Affinity Comparison of p3 and p8 Peptide Displaying Bacteriophages Using Surface Plasmon Resonance, Anal. Chem. 2013, 85, 10075−10082.
J. Lu et al., Fiber optic-SPR platform for fast and sensitive infliximab detection in serum of inflammatory bowel disease patients, Biosensors and Bioelectronics 79 (2016) 173–179.
J. Lu et al., Immunoassay for Detection of Infliximab in Whole Blood Using a Fiber-Optic Surface Plasmon Resonance Biosensor, Anal. Chem. 2017, 89, 3664−3671.
J. Pollet et al., Fast and accurate peanut allergen detection with nanobead enhanced optical fiber SPR biosensor , Talanta 83 (2011) 1436–1441
D. Daems et al., Competitive inhibition assay for the detection of progesterone in dairy milk using a fiber optic SPR biosensor , Analytica Chimica Acta 950 (2017) 1e6.
B. Peeters et al., Real-Time FO-SPR Monitoring of Solid-Phase DNAzyme Cleavage Activity for Cutting-Edge Biosensing, ACS Appl. Mater. Interfaces 2019, 11, 7, 6759–6768.
K. Knez et al., Real-time ligation chain reaction for DNA quantification and identification on the FO-SPR, Biosensors and Bioelectronics 2015, 65, 394-399.